Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 IgG4-related disease revealed by 68Ga-FAPI and 18F-FDG PET/CT.

Literature DB >> 31410541

IgG4-related disease revealed by ⁶⁸Ga-FAPI and ¹⁸F-FDG PET/CT.

Yaping Luo^1,2, Qingqing Pan^3,4, Wen Zhang⁵.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2019 PMID： 31410541 DOI： 10.1007/s00259-019-04478-2

Source DB: PubMed Journal: Eur J Nucl Med Mol Imaging ISSN： 1619-7070 Impact factor: 9.236

× No keyword cloud information.

5 in total

Review 1. Pathological features of IgG4-related sclerosing disease.

Authors: Thomas C Smyrk
Journal: Curr Opin Rheumatol Date: 2011-01 Impact factor: 5.006

2. Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation Protein.

Authors: Thomas Lindner; Anastasia Loktev; Annette Altmann; Frederik Giesel; Clemens Kratochwil; Jürgen Debus; Dirk Jäger; Walter Mier; Uwe Haberkorn
Journal: J Nucl Med Date: 2018-04-06 Impact factor: 10.057

Review 3. IgG4-related sclerosing disease: a critical appraisal of an evolving clinicopathologic entity.

Authors: Wah Cheuk; John K C Chan
Journal: Adv Anat Pathol Date: 2010-09 Impact factor: 3.875

4. Development of Fibroblast Activation Protein-Targeted Radiotracers with Improved Tumor Retention.

Authors: Anastasia Loktev; Thomas Lindner; Eva-Maria Burger; Annette Altmann; Frederik Giesel; Clemens Kratochwil; Jürgen Debus; Frederik Marmé; Dirk Jäger; Walter Mier; Uwe Haberkorn
Journal: J Nucl Med Date: 2019-03-08 Impact factor: 10.057

5. ⁶⁸Ga-FAPI PET/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers.

Authors: Frederik L Giesel; Clemens Kratochwil; Thomas Lindner; Manfred M Marschalek; Anastasia Loktev; Wencke Lehnert; Jürgen Debus; Dirk Jäger; Paul Flechsig; Annette Altmann; Walter Mier; Uwe Haberkorn
Journal: J Nucl Med Date: 2018-08-02 Impact factor: 10.057

5 in total

16 in total

1. Elevated [⁶⁸Ga]Ga-DOTA-FAPI-04 activity in degenerative osteophyte in a patient with lung cancer.

Authors: Huipan Liu; Yingwei Wang; Wei Zhang; Liang Cai; Yue Chen
Journal: Eur J Nucl Med Mol Imaging Date: 2020-11-12 Impact factor: 9.236

2. Imaging fibroblast activation protein in liver cancer: a single-center post hoc retrospective analysis to compare [⁶⁸Ga]Ga-FAPI-04 PET/CT versus MRI and [¹⁸F]-FDG PET/CT.

Authors: Wei Guo; Yizhen Pang; Lanlin Yao; Liang Zhao; Chunlei Fan; Jingpeng Ke; Ping Guo; Bing Hao; Hao Fu; Chengrong Xie; Qin Lin; Hua Wu; Long Sun; Haojun Chen
Journal: Eur J Nucl Med Mol Imaging Date: 2020-11-11 Impact factor: 9.236

3. Usefulness of [⁶⁸Ga]Ga-DOTA-FAPI-04 PET/CT in patients presenting with inconclusive [¹⁸F]FDG PET/CT findings.

Authors: Haojun Chen; Liang Zhao; Dan Ruan; Yizhen Pang; Bing Hao; Yaqing Dai; Xiurong Wu; Wei Guo; Chunlei Fan; Jingxun Wu; Weipeng Huang; Qin Lin; Long Sun; Hua Wu
Journal: Eur J Nucl Med Mol Imaging Date: 2020-06-25 Impact factor: 9.236

4. Value of [⁶⁸Ga]Ga-FAPI-04 imaging in the diagnosis of renal fibrosis.

Authors: Yue Zhou; Xin Yang; Huipan Liu; Wenbin Luo; Hanxiang Liu; Taiyong Lv; Junzheng Wang; Jianhua Qin; Santao Ou; Yue Chen
Journal: Eur J Nucl Med Mol Imaging Date: 2021-04-07 Impact factor: 9.236

5. The potential utility of [⁶⁸ Ga]Ga-DOTA-FAPI-04 as a novel broad-spectrum oncological and non-oncological imaging agent-comparison with [¹⁸F]FDG.

Authors: Lianjun Lan; Hanxiang Liu; Yingwei Wang; Jia Deng; Dengsai Peng; Yue Feng; Li Wang; Yue Chen; Lin Qiu
Journal: Eur J Nucl Med Mol Imaging Date: 2021-08-19 Impact factor: 9.236

Review 6. Clinical summary of fibroblast activation protein inhibitor-based radiopharmaceuticals: cancer and beyond.

Authors: Mengting Li; Muhsin H Younis; Yongxue Zhang; Weibo Cai; Xiaoli Lan
Journal: Eur J Nucl Med Mol Imaging Date: 2022-01-31 Impact factor: 10.057

7. Non-malignant findings of focal ⁶⁸Ga-FAPI-04 uptake in pancreas.

Authors: Xiao Zhang; Wenyu Song; Chunxia Qin; Fang Liu; Xiaoli Lan
Journal: Eur J Nucl Med Mol Imaging Date: 2021-01-15 Impact factor: 9.236

Review 8. Clinical Results of Fibroblast Activation Protein (FAP) Specific PET and Implications for Radiotherapy Planning: Systematic Review.

Authors: Paul Windisch; Daniel R Zwahlen; Stefan A Koerber; Frederik L Giesel; Jürgen Debus; Uwe Haberkorn; Sebastian Adeberg
Journal: Cancers (Basel) Date: 2020-09-15 Impact factor: 6.639

9. ⁶⁸Ga-FAPI-04 PET/MR is helpful in differential diagnosis of pancreatitis from pancreatic malignancy compared to ¹⁸F-FDG PET/CT: a case report.

Authors: Yi Shou; Qiaoyi Xue; Jianmin Yuan; Jun Zhao
Journal: Eur J Hybrid Imaging Date: 2021-06-15

10. Discovery of potential imaging and therapeutic targets for severe inflammation in COVID-19 patients.

Authors: Hyung-Jun Im; Kwon Joong Na; Hongyoon Choi; Hyunjong Lee; Jeongbin Park
Journal: Sci Rep Date: 2021-07-08 Impact factor: 4.379